Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.34B
| $44.4K | ﹤0.01% |
380
-550
| -59% | -$60.2K |
|
4652
Nkarta
NKTX
$176M
| $44.4K | ﹤0.01% |
26,755
-11,069
| -29% | -$20.3K |
|
4653
Aclaris Therapeutics
ACRS
$868M
| $44.3K | ﹤0.01% |
31,205
+25,056
| +407% | +$33.9K |
|
|
FSP
4654
Franklin Street Properties
FSP
$45.3M
| $44.3K | ﹤0.01% |
27,012
-42,761
| -61% | -$71.3K |
|
4655
BV Financial
BVFL
$183M
| $44.3K | ﹤0.01% |
2,907
-11,157
| -79% | -$168K |
|
4656
Mistras Group
MG
$502M
| $44.2K | ﹤0.01% |
5,523
-10,356
| -65% | -$87.1K |
|
4657
iShares MSCI Europe Financials ETF
EUFN
$4.29B
| $44.2K | ﹤0.01% |
1,397
| – | – |
|
|
MDV
4658
Modiv Industrial
MDV
$188M
| $44.2K | ﹤0.01% |
3,138
+2,193
| +232% | +$32.5K |
|
|
AGEN
4659
Agenus
AGEN
$315M
| $44.2K | ﹤0.01% |
9,665
-6,775
| -41% | -$23.5K |
|
4660
Peoples Bancorp of North Carolina
PEBK
$228M
| $44.1K | ﹤0.01% |
1,528
-1,544
| -50% | -$42.8K |
|
4661
Eastern Company
EML
$149M
| $44K | ﹤0.01% |
1,929
-1,676
| -46% | -$37.7K |
|
4662
LENSAR
LNSR
$73.9M
| $44K | ﹤0.01% |
+3,341
| New | +$45.1K |
|
4663
HF Foods Group
HFFG
$83.4M
| $43.9K | ﹤0.01% |
13,812
-14,255
| -51% | -$54.3K |
|
4664
Vivid Seats
SEAT
$82.6M
| $43.7K | ﹤0.01% |
1,293
-1,625
| -56% | -$69.5K |
|
4665
Gyre Therapeutics
GYRE
$713M
| $43.6K | ﹤0.01% |
5,937
+1,084
| +22% | +$9.46K |
|
4666
STRATUS PPTYS INC
STRS
$154M
| $43.6K | ﹤0.01% |
2,307
-1,610
| -41% | -$29.4K |
|
|
BFIN
4667
DELISTED
BankFinancial
BFIN
| $43.3K | ﹤0.01% |
3,744
+2,334
| +166% | +$27.9K |
|
4668
Hamilton Beach Brands
HBB
$444M
| $43.2K | ﹤0.01% |
2,414
-3,258
| -57% | -$57.8K |
|
|
DRUG
4669
Bright Minds Biosciences
DRUG
$793M
| $43.1K | ﹤0.01% |
1,632
+1,631
| +163,100% | +$48.9K |
|
|
PLL
4670
DELISTED
Piedmont Lithium
PLL
| $43.1K | ﹤0.01% |
7,409
-5,405
| -42% | -$35.3K |
|
|
TSE
4671
DELISTED
Trinseo
TSE
| $43.1K | ﹤0.01% |
13,820
+8,128
| +143% | +$26.8K |
|
4672
American Outdoor Brands
AOUT
$160M
| $43.1K | ﹤0.01% |
4,123
-3,320
| -45% | -$38K |
|
|
STLN
4673
Starling Oncology, Inc. Common Stock
STLN
$628M
| $43K | ﹤0.01% |
20,960
+20,957
| +698,567% | +$52.4K |
|
|
NB
4674
NioCorp Developments
NB
$793M
| $42.9K | ﹤0.01% |
+18,420
| New | +$45.9K |
|
4675
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.91B
| $42.8K | ﹤0.01% |
408
-61
| -13% | -$6.06K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.